CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms

by | Jul 22, 2025 | Clinical Trials | 0 comments

​ Conditions: Relapsed or Refractory Plasma Cell Neoplasms

Interventions: Other: CAR19BCMA-T cells

Sponsors: Chinese PLA General Hospital

Not yet recruiting Conditions: Relapsed or Refractory Plasma Cell Neoplasms
Interventions: Other: CAR19BCMA-T cells
Sponsors: Chinese PLA General Hospital
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *